CCNC and cancer: The identification of cancer types where CDK8/CDK19/CCNC are frequently amplified or where their expression correlates with survival suggests a potential role of CDK8/19 in the pathogenesis of such cancers or their treatment response, but it does not automatically mean that such cancers will respond to CDK8/19 inhibitor therapy.